Virpax Pharmaceuticals Inc VRPX:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/24/22 EDT
1.51quote price arrow up+0.01 (+0.67%)
Volume
61,466
52 week range
1.19 - 36.00
Loading...
  • Open1.44
  • Day High1.58
  • Day Low1.44
  • Prev Close1.50
  • 52 Week High36.00
  • 52 Week High Date08/18/21
  • 52 Week Low1.19
  • 52 Week Low Date05/24/22

Key Stats

  • Market Cap17.68M
  • Shares Out11.71M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-55.98

KEY STATS

  • Open1.44
  • Day High1.58
  • Day Low1.44
  • Prev Close1.50
  • 52 Week High36.00
  • 52 Week High Date08/18/21
  • 52 Week Low1.19
  • 52 Week Low Date05/24/22
  • Market Cap17.68M
  • Shares Out11.71M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-55.98

RATIOS/PROFITABILITY

  • EPS (TTM)-1.80
  • P/E (TTM)-0.84
  • Fwd P/E (NTM)-1.13
  • EBITDA (TTM)-14.801M
  • ROE (TTM)-70.35%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Virpax Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems. The Company's drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients' quality of life. The Company's portfolio consists of product candidates, such...
Address
1554 Paoli Pike #279, #279
West Chester, PA
19380
United States